Branded

04/11/2014 - 11:08am

Teva Pharmaceuticals and the Parkinson's Unity Walk on Friday announced the launch of a public awareness campaign, "CommUNITY: Carrying the PD Torch," to support Parkinson's disease patients during Parkinson's Disease Awareness Month in April.

04/11/2014 - 10:11am

Ian Read, chairman and CEO of Pfizer, was elected chairman of the Pharmaceutical Research and Manufacturers of America at the trade association’s annual meeting.

04/09/2014 - 10:17am

According to new survey data recently released by the National Consumers League, one-third of adult Americans still believe that vaccines may be linked to autism in children.

04/08/2014 - 11:06am

Ohio Gov. John Kasich got his first look on Tuesday at what’s being called a next-generation pharmaceutical distribution center — under construction in central Ohio.

04/08/2014 - 9:48am

Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.

04/08/2014 - 8:07am

Healthcare Distribution Management Association president and CEO John Gray on Monday testified before the House Energy and Commerce Subcommittee on Health at a hearing on “Improving Predictability and Transparency in DEA and FDA Regulation.”

04/07/2014 - 11:28am

Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration has approved Pradaxa (dabigatran etexilate mesylate), which is used to treat deep venous thrombosis and pulmonary embolism.

04/07/2014 - 11:26am

Mallinckrodt and Questcor Pharmaceuticals on Monday announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion.

04/04/2014 - 2:54pm

Medication nonadherence is common, but it may be reduced by lower drug costs and co-payments, as well as increased follow-up care, according to a study published earlier this week in the Annals of Internal Medicine.

04/04/2014 - 8:34am

IMS Health Holdings on Thursday announced the pricing of its initial public offering of 65 million shares of its common stock at a price to the public of $20 per share, including 52 million shares to be sold by IMS Health and 13 million shares to be sold by selling shareholders.